BANK OF AMERICA CORP /DE/ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$7,866
-15.5%
34,201
+30.1%
0.00%
Q1 2023$9,306
-28.0%
26,288
-34.9%
0.00%
Q4 2022$12,926
-71.9%
40,394
-36.1%
0.00%
Q3 2022$46,000
-56.6%
63,203
-46.4%
0.00%
Q2 2022$106,000
+221.2%
117,868
+424.2%
0.00%
Q1 2022$33,000
-54.8%
22,485
-32.8%
0.00%
Q4 2021$73,000
-26.3%
33,475
+20.1%
0.00%
Q3 2021$99,000
-34.4%
27,868
+5.7%
0.00%
Q2 2021$151,000
-43.0%
26,370
-48.3%
0.00%
Q1 2021$265,000
+813.8%
51,053
+313.1%
0.00%
Q4 2020$29,00012,359
+13944.3%
0.00%
Q3 2020$0
-100.0%
88
-99.1%
0.00%
Q2 2020$19,000
+850.0%
9,864
+1401.4%
0.00%
Q1 2020$2,000
-66.7%
657
-74.2%
0.00%
Q4 2019$6,000
-53.8%
2,542
-59.6%
0.00%
Q3 2019$13,000
+30.0%
6,285
+47.1%
0.00%
Q2 2019$10,000
-67.7%
4,272
-45.3%
0.00%
Q1 2019$31,000
+287.5%
7,803
+145.8%
0.00%
Q2 2018$8,000
+300.0%
3,175
+485.8%
0.00%
Q1 2018$2,000
-33.3%
542
-22.9%
0.00%
Q4 2017$3,000
-25.0%
703
+24.9%
0.00%
Q3 2017$4,000
+300.0%
563
+120.8%
0.00%
Q2 2017$1,000
-50.0%
2550.0%0.00%
Q1 2017$2,000
-33.3%
255
-45.4%
0.00%
Q4 2016$3,000
+200.0%
467
+61.6%
0.00%
Q3 2016$1,000
-50.0%
289
-55.3%
0.00%
Q2 2016$2,000
-84.6%
647
-77.2%
0.00%
Q1 2016$13,0002,8420.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders